Showing results (1511-1520 of 3,660) with videos related to
Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|September 21, 2020
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in GermanyAndreas Schneeweiss, Johannes Ettl, Diana Lüftner, et al.Breast (Edinburgh, Scotland)|September 21, 2020
Orthotopic grafting of decellularized human nipple: Setting the stage and putative mechanism of healingPeter C Johnson, Gerald L KleinBreast (Edinburgh, Scotland)|November 26, 2020
A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomitingM Clemons, G Dranitsaris, M Sienkiewicz, et al.Breast (Edinburgh, Scotland)|November 26, 2020
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)Luis Manso, Cristina Hernando, María Galán, et al.Breast (Edinburgh, Scotland)|January 2, 2021
Decisional conflict in breast cancer patients considering immediate breast reconstructionJacqueline A Ter Stege, Hester S A Oldenburg, Leonie A E Woerdeman, et al.Breast (Edinburgh, Scotland)|December 20, 2020
A systematic review and meta-analysis on the effect of neoadjuvant chemotherapy on complications following immediate breast reconstructionJajini Varghese, Shireen S Gohari, Hirah Rizki, et al.Breast (Edinburgh, Scotland)|December 20, 2020
Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancerJunji Tsurutani, Fumikata Hara, Masahiro Kitada, et al.Breast (Edinburgh, Scotland)|December 14, 2020
Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in ChinaYiqun Li, Qiao Li, Hongnan Mo, et al.Breast (Edinburgh, Scotland)|December 14, 2020
Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysisDong-Yun Kim, Eonju Park, Chan Yeong Heo, et al.Breast (Edinburgh, Scotland)|November 1, 2020
Occult breast cancer: Where are we at?Adam Ofri, Katrina MoorePageof 366